Michael Abrams

Several states have proposed legislation restricting the use of state funds to purchase opioid antagonists from entities that have entered into an opioid-related litigation settlement regarding misconduct in the sale or distribution of prescription opioids. As they consider whether these laws are in the best interests of both taxpayers and people at risk of overdose, policymakers and advocates should consider the negative effect such laws would likely have on access to lifesaving overdose reversal medications.

Preliminary data indicates that overdose mortality declined significantly in 2024, with one exception, elder Black men. One 2022 study found that deaths among Black men aged 19-30 years are expected to decline by 9 percent in 2025 relative to 2020, while deaths among Black men aged 31-47 years are expected to rise by 11 percent.

Preliminary data indicates that overdose mortality declined significantly in 2024, with one exception, elder Black men. One 2022 study found that deaths among Black men aged 19-30 years are expected to decline by 9 percent in 2025 relative to 2020, while deaths among Black men aged 31-47 years are expected to rise by 11 percent.

Infections among people who use drugs related to lack of access to new syringes and subsequent syringe sharing among people who inject drugs have increased dramatically. Increasing access to sterile syringes through syringe services programs (SSPs) is an extremely effective strategy for reducing the spread of bloodborne disease among people who use drugs, their partners, and their families. This factsheet discusses the legality of SSPs in Maryland.